These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19236491)

  • 41. Telestroke: Is it safe and effective?
    Madhavan M; Karceski S
    Neurology; 2016 Sep; 87(13):e145-8. PubMed ID: 27672174
    [No Abstract]   [Full Text] [Related]  

  • 42. Intrapleural low-molecular-weight urokinase or tissue plasminogen activator versus single-chain urokinase in tetracycline-induced pleural loculation in rabbits.
    Idell S; Azghani A; Chen S; Koenig K; Mazar A; Kodandapani L; Bdeir K; Cines D; Kulikovskaya I; Allen T
    Exp Lung Res; 2007; 33(8-9):419-40. PubMed ID: 17994370
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of national guidelines while staying abroad with an acute stroke.
    Okazaki S; Fatar M
    Cerebrovasc Dis; 2014; 38(3):161-2. PubMed ID: 25300432
    [No Abstract]   [Full Text] [Related]  

  • 44. Intravenous tissue plasminogen activator in central retinal artery occlusion.
    Falavarjani KG; Modarres M
    Am J Ophthalmol; 2009 Jun; 147(6):1105; author reply 1105-6. PubMed ID: 19463547
    [No Abstract]   [Full Text] [Related]  

  • 45. [Thrombolytic therapy in cerebral infarction].
    Varga V; Waje-Andreassen U; Naess H; Lundstadsveen MT; Thomassen L
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2214-7. PubMed ID: 19898567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endogenous activated protein C predicts hemorrhagic transformation and mortality after tissue plasminogen activator treatment in stroke patients.
    Mendioroz M; Fernández-Cadenas I; Alvarez-Sabín J; Rosell A; Quiroga D; Cuadrado E; Delgado P; Rubiera M; Ribó M; Molina C; Montaner J
    Cerebrovasc Dis; 2009; 28(2):143-50. PubMed ID: 19546541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Desmoteplase.
    Paciaroni M; Medeiros E; Bogousslavsky J
    Expert Opin Biol Ther; 2009 Jun; 9(6):773-8. PubMed ID: 19456211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein.
    Yamamoto T; Kamei M; Sakaguchi H; Oshima Y; Ikuno Y; Gomi F; Ohji M; Tano Y
    Retina; 2009 Sep; 29(8):1167-74. PubMed ID: 19734765
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Think Twice Before Using This Abbreviation.
    Paparella SF
    J Emerg Nurs; 2019 Jan; 45(1):85-87. PubMed ID: 30616768
    [No Abstract]   [Full Text] [Related]  

  • 50. Stroke of luck.
    Raymond MK
    RN; 2008 Nov; 71(11):8. PubMed ID: 19090074
    [No Abstract]   [Full Text] [Related]  

  • 51. A new technique for the subretinal injection of small volumes by using a modified viscous fluid injector system.
    Kayikcioglu OR; Mendez T; Morrison V; Freeman WR
    Retina; 2006; 26(9):1089-90. PubMed ID: 16622393
    [No Abstract]   [Full Text] [Related]  

  • 52. Pre admission antithrombotics are associated with improved outcomes following ischaemic stroke: a cohort from the Registry of the Canadian Stroke Network.
    Dowlatshahi D; Hakim A; Fang J; Sharma M;
    Int J Stroke; 2009 Oct; 4(5):328-34. PubMed ID: 19765119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tissue plasminogen activator does not benefit most eligible patients with stroke.
    Lansberg MG; Schwartz NE
    Arch Neurol; 2009 Apr; 66(4):540-1; author reply 541. PubMed ID: 19364946
    [No Abstract]   [Full Text] [Related]  

  • 54. [Current status and future of recombinant tissue plasminogen activator for acute ischemic stroke].
    Sakaida H; Taki W
    No Shinkei Geka; 2009 Nov; 37(11):1067-83. PubMed ID: 19938663
    [No Abstract]   [Full Text] [Related]  

  • 55. eComment: Systemic thrombolysis with alteplase in impending paradoxical embolism.
    Misfeld M; Hanke T
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):714. PubMed ID: 19773241
    [No Abstract]   [Full Text] [Related]  

  • 56. Acute ischemic stroke: Not a moment to lose.
    Miller J; Mink J
    Nursing; 2009 May; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of the stroke code activation source on the outcome of acute ischemic stroke patients.
    Whitcomb DS
    Neurology; 2009 May; 72(19):1709; author reply 1710. PubMed ID: 19433750
    [No Abstract]   [Full Text] [Related]  

  • 58. Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.
    Sharma VK; Tsivgoulis G; Tan JH; Ong BK; Chan BP; Teoh HL
    Int J Stroke; 2009 Oct; 4(5):320-1. PubMed ID: 19765117
    [No Abstract]   [Full Text] [Related]  

  • 59. Acute stroke therapy with tissue plasminogen activator (tPA) since it was approved by the U.S. Food and Drug Administration (FDA).
    Zivin JA
    Ann Neurol; 2009 Jul; 66(1):6-10. PubMed ID: 19681102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Guidelines for the general management of patients with acute ischemic stroke].
    Chang YJ; Ryu SJ; Chen JR; Hu HH; Yip PK; Chiu TF;
    Acta Neurol Taiwan; 2008 Dec; 17(4):275-94. PubMed ID: 19280874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.